Poly Medicure Limited announced strong financial results for the quarter and year ended March 31, 2026. The Board of Directors recommended a final dividend of ₹3.5 per equity share (70% of face value). The company also reported significant milestones, including successful international acquisitions and the strategic deployment of funds from its Qualified Institutional Placement (QIP), strengthening its leadership position in the global medical device sector.
Annual and Quarterly Financial Highlights
For the financial year ended March 31, 2026, Poly Medicure Limited delivered robust performance. On a consolidated basis, the company achieved total income from operations of ₹1,99,534.14 lacs for the year. Net profit for the year stood at ₹32,072.99 lacs, reflecting the company’s sustained growth trajectory in the medical devices market.
Strategic Dividend Recommendation
Reflecting its commitment to shareholder value, the Board has recommended a dividend of ₹3.5 per equity share, representing 70% of the ₹5 face value for the 2025-26 financial year. This recommendation is currently pending approval by the shareholders.
Corporate Expansion and Acquisitions
The company continues to pursue inorganic growth. During the 2025-26 financial year, the group successfully acquired a 90% economic interest in the Pendracare Group, which includes Pendracare Holdings BV and Welling Medical BV. Additionally, the company is finalizing the acquisition of Medistream SA (Citieffe group) and has initiated the acquisition process for Himalayan Mineral Water Private Limited, following approval from the NCLT.
Capital Utilization
The company effectively utilized the proceeds from its QIP. A significant portion was allocated to capital expenditure (₹6,198.32 lacs) and inorganic initiatives (₹25,026.84 lacs). As of March 31, 2026, approximately ₹48,427.79 lacs was kept in liquid mutual funds and fixed deposits, ensuring the company maintains a strong liquidity position for future operational requirements.
Leadership and Governance
The company also confirmed the re-appointment of its auditors for the 2026-27 fiscal year, specifically PricewaterhouseCoopers Services LLP and Oswal Sunil & Co. Chartered Accountants, to maintain high standards of financial oversight and corporate governance.
Source: BSE
